CIK 0001856725
- Emerging growth company
Rani Therapeutics Holdings, Inc.
Sign in to watch- Ticker
- RANI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 863114789
- Phone
- +1 408-457-3700
- Business address
- 47709 FREMONT BLVD, FREMONT, CA, 94538
- 4 Open-market buy 10% owner bought 3,587 shares at $5.23 ($18,749)
- 4 Open-market buy 10% owner bought 12,981 shares at an average $4.80 ($62,374)
- 4 Open-market buy 10% owner bought 3,510 shares at $5.49 ($19,283)
- 4 Grant or award GENERAL COUNSEL acquired 139,000 shares (grant or award)
- 4 Grant or award CHIEF SCIENTIFIC OFFICER acquired 139,000 shares (grant or award)
- 4 Grant or award CFO acquired 139,000 shares (grant or award)
- 4 Grant or award CEO acquired 353,500 shares (grant or award)
- 4 Shares withheld for taxes CFO gave up 3,355 shares (to pay taxes)
- 4 Shares withheld for taxes General Counsel gave up 2,498 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 7,988 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 4,201 shares (to pay taxes)
- 4 Open-market buy 10% owner bought 3,762 shares at an average $6.11 ($22,985)
- 4 Open-market buy 10% owner bought 4,305 shares at an average $6.15 ($26,493)
- 4 Open-market buy 10% owner bought 2,463 shares at $6.14 ($15,121)
- 4 Open-market buy 10% owner bought 5,432 shares at an average $6.57 ($35,689)
- 4 Open-market buy 10% owner bought 1,100 shares at $6.39 ($7,032)
- 4 Open-market buy 10% owner bought 3,900 shares at $6.31 ($24,609)
- 4 Open-market buy 10% owner bought 711 shares at $6.30 ($4,478)
- 4 Open-market buy 10% owner bought 8,992 shares at an average $6.17 ($55,488)
- 4 Open-market buy 10% owner bought 4,080 shares at an average $5.98 ($24,400)
Page 6 of 10 · 194 filings